Page last updated: 2024-09-03

glycylglutamine and mecamylamine

glycylglutamine has been researched along with mecamylamine in 1 studies

Compound Research Comparison

Studies
(glycylglutamine)
Trials
(glycylglutamine)
Recent Studies (post-2010)
(glycylglutamine)
Studies
(mecamylamine)
Trials
(mecamylamine)
Recent Studies (post-2010) (mecamylamine)
1048141,99768376

Protein Interaction Comparison

ProteinTaxonomyglycylglutamine (IC50)mecamylamine (IC50)
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)0.44
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)2.0833
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)1.6133
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)1.8
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)0.6
Neuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)3.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavun, S; Göktalay, G; Hamilton, JR; Levendusky, MC; Millington, WR1

Other Studies

1 other study(ies) available for glycylglutamine and mecamylamine

ArticleYear
Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Avoidance Learning; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors

2006